Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    [edited by] Edgar V. Lerma, James M. Luther, Swapnil Hiremath.
    Contents:
    Measurement of blood pressure in the office
    Ambulatory and home blood pressure monitoring
    Clinical evaluation of the patient with hypertension
    Hypertensive emergencies and urgencies
    The epidemiology of hypertension
    Physiology of blood pressure regulation
    Target organ damage or why should we treat hypertension?
    Primary aldosteronism and mineralocorticoid hypertension
    Glucocorticoid hypertension
    Pheochromocytoma and paraganglioma
    Other endocrine causes of hypertension
    Renovascular hypertension
    Drug-induced hypertension
    Obstructive sleep apnea and hypertension
    Hereditary causes of hypertension
    Hypertension in children and adolescents
    Hypertension in chronic kidney disease and end-stage kidney disease
    Hypertension in diabetes
    Hypertension after transplantation
    Treatment of hypertension in obesity
    Hypertension in blacks
    Hypertension in the elderly
    Hypertension in pregnancy
    Hypertension in heart disease
    Hypertension in stroke
    Hypertension in the patient with aortic dissection
    Resistant and pseudoresistant hypertension
    Hyperkalemia in hypertension
    Lifestyle modifications for hypertension management
    Blood pressure treatment goals
    Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker
    Calcium channel blockers
    Direct vasodilators
    Loop and thiazide diuretics
    Potassium-sparing diuretics
    Alpha antagonists
    Beta-blockers
    Alpha-agonists
    Drug-drug and pharmacogenetic interactions
    Role of device therapy
    Orthostatic hypotension
    Baroreflex dysfunction
    Hypertension: origins.
    Digital Access ClinicalKey 2023
  • Article
    Kreutner AK, del Bene VE, Delamar D, Huguley V, Harmon PM, Mitchell KS.
    Obstet Gynecol. 1978 Sep;52(3):279-84.
    The effect of an 8-hour, 3-dose perioperative regimen of cefazolin or placebo was evaluated in 97 patients. Postoperative morbidity occurred in 13 patients (27.1%) in the cefazolin group and in 17 patients (34.7%) who received placebo. The clinical sites of infection were similar in both groups except that wound infections (2) and sepsis (2) were found only in patients receiving placebo. Aerobic organisms diminished and anaerobes increased in patients who received antibiotics. Aerobic isolates were essentially unchanged and fewer anaerobes were recovered from patients given placebo. Antibiotic levels observed at cesarean section were in the therapeutic range. The only risk factor which correlated with morbidity was the presence of ruptured membranes. This short course, single drug regimen did not significantly reduce morbidity although it was bacteriologically effective.
    Digital Access Access Options